SEARCH

SEARCH BY CITATION

References

  • 1
    de Visser KE,Eichten A,Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6: 2437.
  • 2
    Ness RB,Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999; 91: 145967.
  • 3
    Ness RB,Grisso JA,Cottreau C,Klapper J,Vergona R,Wheeler JE,Morgan M,Schlesselman JJ. Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 2000; 11: 11117.
  • 4
    Curiel TJ,Coukos G,Zou L,Alvarez X,Cheng P,Mottram P,Evdemon-Hogan M,Conejo-Garcia JR,Zhang L,Burow M,Zhu Y,Wei S, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 9429.
  • 5
    Kulbe H,Thompson R,Wilson JL,Robinson S,Hagemann T,Fatah R,Gould D,Ayhan A,Balkwill F. The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res 2007; 67: 58592.
  • 6
    Koczulla R,von Degenfeld G,Kupatt C,Krotz F,Zahler S,Gloe T,Issbrucker K,Unterberger P,Zaiou M,Lebherz C,Karl A,Raake P, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003; 111: 166572.
  • 7
    Sorensen OE,Cowland JB,Theilgaard-Monch K,Liu L,Ganz T,Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003; 170: 55839.
  • 8
    Heilborn JD,Nilsson MF,Kratz G,Weber G,Sorensen O,Borregaard N,Stahle-Backdahl M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003; 120: 37989.
  • 9
    Dorschner RA,Pestonjamasp VK,Tamakuwala S,Ohtake T,Rudisill J,Nizet V,Agerberth B,Gudmundsson GH,Gallo RL. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001; 117: 917.
  • 10
    Frohm M,Gunne H,Bergman AC,Agerberth B,Bergman T,Boman A,Liden S,Jornvall H,Boman HG. Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 1996; 237: 8692.
  • 11
    Shaykhiev R,Beisswenger C,Kandler K,Senske J,Puchner A,Damm T,Behr J,Bals R. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 2005; 289: L842L848.
  • 12
    Kim ST,Cha HE,Kim DY,Han GC,Chung YS,Lee YJ,Hwang YJ,Lee HM. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol 2003; 123: 815.
  • 13
    Schauber J,Rieger D,Weiler F,Wehkamp J,Eck M,Fellermann K,Scheppach W,Gallo RL,Stange EF. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2006; 18: 61521.
  • 14
    Sorensen OE,Gram L,Johnsen AH,Andersson E,Bangsboll S,Tjabringa GS,Hiemstra PS,Malm J,Egesten A,Borregaard N. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem 2003; 278: 285406.
  • 15
    Sorensen OE,Follin P,Johnsen AH,Calafat J,Tjabringa GS,Hiemstra PS,Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001; 97: 39519.
  • 16
    Zaiou M,Nizet V,Gallo RL. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. JInvest Dermatol 2003; 120: 81016.
  • 17
    Jacobsen F,Mittler D,Hirsch T,Gerhards A,Lehnhardt M,Voss B,Steinau HU,Steinstraesser L. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther 2005; 12: 1494502.
  • 18
    Scott MG,Davidson DJ,Gold MR,Bowdish D,Hancock RE. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 2002; 169: 388391.
  • 19
    Tjabringa GS,Aarbiou J,Ninaber DK,Drijfhout JW,Sorensen OE,Borregaard N,Rabe KF,Hiemstra PS. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003; 171: 66906.
  • 20
    Zuyderduyn S,Ninaber DK,Hiemstra PS,Rabe KF. The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells. J Allergy Clin Immunol 2006; 117: 132835.
  • 21
    Agerberth B,Gunne H,Odeberg J,Kogner P,Boman HG,Gudmundsson GH. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995; 92: 1959.
  • 22
    Johansson J,Gudmundsson GH,Rottenberg ME,Berndt KD,Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 1998; 273: 371824.
  • 23
    Yang D,Chen Q,Schmidt AP,Anderson GM,Wang JM,Wooters J,Oppenheim JJ,Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000; 192: 106974.
  • 24
    Turner J,Cho Y,Dinh NN,Waring AJ,Lehrer RI. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 1998; 42: 220614.
  • 25
    Niyonsaba F,Iwabuchi K,Someya A,Hirata M,Matsuda H,Ogawa H,Nagaoka I. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002; 106: 206.
  • 26
    Tjabringa GS,Ninaber DK,Drijfhout JW,Rabe KF,Hiemstra PS. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol 2006; 140: 10312.
  • 27
    Tokumaru S,Sayama K,Shirakata Y,Komatsuzawa H,Ouhara K,Hanakawa Y,Yahata Y,Dai X,Tohyama M,Nagai H,Yang L,Higashiyama S, et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 2005; 175: 46628.
  • 28
    Abboud ER,Coffelt SB,Figueroa YG,Zwezdaryk KJ,Nelson AB,Sullivan DE,Morris CB,Tang Y,Beckman BS,Scandurro AB. Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. Int J Oncol 2007; 30: 11322.
  • 29
    Hase K,Eckmann L,Leopard JD,Varki N,Kagnoff MF. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70: 95363.
  • 30
    Freedman RS,Deavers M,Liu J,Wang E. Peritoneal inflammation—a microenvironment for Epithelial Ovarian Cancer (EOC). J Transl Med 2004; 2: 23.
  • 31
    Agerberth B,Charo J,Werr J,Olsson B,Idali F,Lindbom L,Kiessling R,Jornvall H,Wigzell H,Gudmundsson GH. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96: 308693.
  • 32
    Heilborn JD,Nilsson MF,Jimenez CI,Sandstedt B,Borregaard N,Tham E,Sorensen OE,Weber G,Stahle M. Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 2005; 114: 71319.
  • 33
    Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update 2005; 11: 46171.
  • 34
    Edfeldt K,Agerberth B,Rottenberg ME,Gudmundsson GH,Wang XB,Mandal K,Xu Q,Yan ZQ. Involvement of the antimicrobial peptide LL-37 in human atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26: 15517.
  • 35
    Oren Z,Lerman JC,Gudmundsson GH,Agerberth B,Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J 1999; 341 (Part 3): 50113.
  • 36
    Li Y,Li X,Li H,Lockridge O,Wang G. A novel method for purifying recombinant human host defense cathelicidin LL-37 by utilizing its inherent property of aggregation. Protein Expr Purif 2007; 54: 15765.
  • 37
    Yamasaki K,Schauber J,Coda A,Lin H,Dorschner RA,Schechter NM,Bonnart C,Descargues P,Hovnanian A,Gallo RL. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 2006; 20: 206880.
  • 38
    Prezas P,Arlt MJ,Viktorov P,Soosaipillai A,Holzscheiter L,Schmitt M,Talieri M,Diamandis EP,Kruger A,Magdolen V. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem 2006; 387: 80711.
  • 39
    Dong Y,Kaushal A,Brattsand M,Nicklin J,Clements JA. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 2003; 9: 171020.
  • 40
    Kim H,Scorilas A,Katsaros D,Yousef GM,Massobrio M,Fracchioli S,Piccinno R,Gordini G,Diamandis EP. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer 2001; 84: 64350.
  • 41
    Huang LC,Petkova TD,Reins RY,Proske RJ,McDermott AM. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci 2006; 47: 236980.
  • 42
    Schmidtchen A,Frick IM,Andersson E,Tapper H,Bjorck L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 2002; 46: 15768.
  • 43
    Andersson E,Rydengard V,Sonesson A,Morgelin M,Bjorck L,Schmidtchen A. Antimicrobial activities of heparin-binding peptides. Eur J Biochem 2004; 271: 121926.
  • 44
    Baranska-Rybak W,Sonesson A,Nowicki R,Schmidtchen A. Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids. J Antimicrob Chemother 2006; 57: 2605.
  • 45
    Felgentreff K,Beisswenger C,Griese M,Gulder T,Bringmann G,Bals R. The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides 2006; 27: 31006.
  • 46
    Egeblad M,Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 16174.